|
KMID : 1035620200080010003
|
|
Allergy Asthma & Respiratory Disease
2020 Volume.8 No. 1 p.3 ~ p.8
|
|
|
Cystic fibrosis lung disease: Current perspectives
|
|
Jung Jin-A
|
|
|
Abstract
|
|
|
|
Cystic fibrosis (CF) is an autosomal recessive disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). These mutations alter the synthesis, processing, function, or half-life of CFTR, the main chloride channel expressed in the apical membrane of epithelial cells in the airway, intestine, pancreas, and reproductive tract. Lung disease is the most critical manifestation of CF. It is characterized by airway obstruction, infection, and inflammation that lead to fatal tissue destruction, which causes most CF morbidity and mortality. This article reviews the pathophysiology of CF, recent animal models, and current treatment of CF.
|
|
|
KEYWORD
|
|
|
Cystic fibrosis, Cystic fibrosis transmembrane conductance regulator, Chloride-bicarbonate transport, Epithelial sodium channel
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|
|